Targeting additional costimulatory pathways: a subtle role for CD2.
Dumont
C
C
Cell Immun Transplant Lab IRSC, CNRS ER 1984, Villejuif and Service de Néphrologie, University Hospital of Bicetre, Kremlin-Bicêtre, France.
Deas
O
O
Hebib
C
C
Durrbach
A
A
Hirsch
F
F
Charpentier
B
B
Senik
A
A
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000494:pharmacology*; D018801:CD2 Antigens / Q000276:immunology* / Q000502:physiology; D018968:CD58 Antigens / Q000502:physiology; D006084:Graft Rejection / Q000188:drug therapy; D016027:Heart Transplantation / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008213:Lymphocyte Activation / Q000187:drug effects*; D051379:Mice; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D023001:Transplantation Tolerance
D000911:Antibodies, Monoclonal; D018801:CD2 Antigens; D018968:CD58 Antigens; D007166:Immunosuppressive Agents; C105249:LO-CD2a